Prostate Cancer & BPHArchives
Sarcomatoid prostate carcinoma: a case report
Prostate Cancer & BPH 2 min.
Sarcomatoid carcinoma (SC) of the prostate represents an extremely rare and aggressive form of prostate cancer, accounting for less than 0.1% of cases. This malignancy is characterized by the presence of both glandular and sarcomatoid components, presenting unique challenges in diagnosis and management....
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe
Prostate Cancer & BPH 6 min.
On the basis of the GLOBOCAN 2022 estimates, prostate cancer (PCa) is the fourth most prevalent cancer in the world [1]. An estimated 470,000 diagnoses and 110,000 deaths were attributed to PCa in Europe alone in 2020 [2]. Androgen deprivation therapy (ADT) is the mainstay treatment for patients with...
Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014–2024
Prostate Cancer & BPH 4 min.
Cabazitaxel (CBZ) in combination with prednisone has been a standard treatment option for patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting since its endorsement by the Food and Drug Administration and European Medical Agency in 2010–2011 [1, 2]. As...
Perioperative anesthesia management for elderly patients with permanent pacemakers undergoing retropubic prostatectomy in Ethiopia East Africa: a case report and review of the literature
Prostate Cancer & BPH 3 min.
An artificial pacemaker is an electrical battery-operated device that acts permanently with the replacement of the natural heart’s pacemaker at the sinoatrial node to regulate heart rhythm because the natural pacemaker (PM) is slowed or electrical conduction is blocked [1]. This device contains...
